Results

Our proven
track record.

  • We represented a University in its spinout of a biopharmaceutical company and subsequent $32 million Series A financing, including an agreement granting exclusive rights to acquire the company and its technology.
  • We represented a specialty pharmaceutical client in its collaboration with a Chinese pharmaceutical company to develop and manufacture pharmaceutical products in China.
  • Our lawyers represented a Singapore-based public company in its joint venture with a privately held U.S. company to develop and market hardware and software products for postal, courier, and logistics markets.
  • We have negotiated joint development agreements with US, Swiss, Canadian, and Chinese pharmaceutical companies relating to both new compounds and generic versions of listed drugs on behalf of biotech and specialty pharmaceutical companies.
  • We represented a U.S. manufacturer in a joint venture with a Chinese partner for the construction of a manufacturing facility in Shanghai.
  • We represented a leading Canadian provider of diagnostic imaging technology in negotiating a series of arrangements to distribute its technology in conjunction with the products of the world’s top medical imaging equipment manufacturers.
  • We represented a U.S.-based pharmaceutical company and its India-based subsidiary in numerous licensing and joint venture transactions with major educational and government organizations in India and represented them in its sale to a British entity. Currently, we represent a principal of the acquired entities in a spin out of these entities, which involves among other issues, special purpose financing arranged through an Indian private equity fund and coordinating U.S. and Indian tax and securities laws.
  • Our lawyers represented a venture capital fund in its collaboration with a publicly traded Dutch company and a US executive in developing a web-based gaming site in the United Kingdom.
RESOURCES

Happenings, headlines and insights.
See what’s new at Davis Malm.

View Our Business Resources

Firm Announcements

November 21, 2019

Davis Malm Adds New Associate to Business Litigation and Employment Practices

Read More

Publications

November 18, 2019

Mass. Cannabis Industry Welcomes Feds’ Regulatory Probe

Read More

Alerts

October 30, 2019

Recent Changes to Massachusetts Cannabis Regulations

Read More

Publications

October 24, 2019

What are the Business Regulations for Cannabis in Massachusetts?

Read More

Publications

October 17, 2019

Andrew Myers Serves on Table of Experts for Boston Business Journal’s “The Business of Cannabis”

Read More

Firm Announcements

October 10, 2019

Davis Malm Adds Accomplished Tax Attorney Phil Olsen to Business Practice

Read More

Firm Announcements

August 20, 2019

Davis Malm Submits Comments to Cannabis Control Commission Regarding Proposed Revisions to Cannabis Regulations

Read More

Alerts

August 8, 2019

Massachusetts Cannabis Control Commission Proposes Revisions to Cannabis Regulations

Read More

Publications

August 7, 2019

Ex-client accuses Bowditch & Dewey of $20M gaffe

Read More
Contact Us

Need Business Counsel?

Get in touch
Scroll to Top